Skip to content

EndometrioSis PRediction and Assessment of InflammaTion

Exploring Pre-operative Prediction of Pelvic Endometriosis, the Local Inflammatory Environment and Response to Surgical Treatment

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07114081
Acronym
ESPRIT
Enrollment
264
Registered
2025-08-11
Start date
2022-07-01
Completion date
2025-08-01
Last updated
2025-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Brief summary

The goal of this observational study is to develop a non-invasive predictive algorithm for a diagnosis of endometriosis in a group of symptomatic women attending for their first laparoscopic surgical procedure for symptoms that are suspicious for pelvic endometriosis and to understand the role of peripheral markers of inflammation in enhancing this diagnosis. The main questions it aims to answer are: Can a non-invasive quantitative algorithm ('Endometriosis Diagnostic Index') accurately predict the presence or absence of pelvic endometriosis? Is the peripheral inflammatory environment (for example, presence of inflammatory cytokines and chemokine) different between people with and without endometriosis?

Interventions

DIAGNOSTIC_TESTDiagnostic laparoscopy

Minimal access surgery to determine the presence of characteristic endometriosis lesions on visual inspection of the pelvis

Sponsors

Imperial College London
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years

Inclusion criteria

• Consecutive female patients age 18-50 undergoing laparoscopy with the suspicion of endometriosis (as indicated by any recording in secondary care medical notes of endometriosis being a possible finding at laparoscopy; all those undergoing laparoscopy for sub-fertility (no conception after ≥6 months of trying, excluding confirmed male factor); or pelvic pain symptoms (dysmenorrhea; non-cyclical pelvic pain; dyspareunia; dyschezia) who is not otherwise excluded.

Exclusion criteria

* previous surgically confirmed endometriosis; * postmenopausal status; * laparoscopy for acute indication (ectopic; tubo-ovarian abscess; adnexal torsion); * suspicion of malignancy; * the sole indication of tubal sterilisation; * the sole indication of myomectomy; * pregnant or breastfeeding; * significant medical co-morbidities including HIV and/or hepatitis B or C infection; * where gynaecology is not the primary team undertaking surgery; * unable to have transvaginal ultrasound (TVUSS); * declines to take part in the study; * patient unable to understand verbal or written information in English; * lack of capacity to consent at the point of recruitment; * known safeguarding issues.

Design outcomes

Primary

MeasureTime frameDescription
Endometriosis predictive model24 monthsMultiple logistic regression model of predictive variables

Secondary

MeasureTime frameDescription
Markers of inflammation24 monthsCytokine multiplex for markers of inflammation in peripheral blood

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026